What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests

被引:0
|
作者
Ishii-Watabe, Akiko [1 ]
机构
[1] Natl Inst Hlth Sci, Div Biol Chem & Biol, Kawasaki Ku, 3-25-26 Tonomachi, Kawasaki, Kanagawa 2109501, Japan
关键词
severe acute respiratory syndrome coronavirus-2; vaccine; antibody test; immunoglobulin G (IgG); immunoglobulin M (IgM);
D O I
10.1248/yakushi.21-00234-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antibodies play a major role in immune responses against viruses, which inhibit infection by binding to target viral antigen. Antibodies are induced by viral entry to the body and vaccination that artificially induces immune responses; therefore, antibody tests are used in research for infection history and evaluation of vaccine efficacy. Currently, antibody tests against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by immunochromatography, enzyme-linked immunosorbent assay (ELISA), and electrochemiluminescence immunoassay (ECLIA), or other kits used for automated analyzer are available. However, the test results should be carefully interpreted because requirements for the antibody test to obtain reliable results have not been established. Also, antibodies in human samples are heterogeneous, and their expression level changes over time. This review briefly explains the basic knowledge about antibodies against SARS-CoV-2 and outlines the classification and characteristics of the antibody tests with points to consider in their use. A summary of the collaborative study that evaluated the analytical performance of antibody test kits conducted by the National Institute of Health Sciences is also introduced. Then, the issues in ensuring the reliability of antibody tests results are discussed by considering the usefulness and availability of the World Health Organization international standard for anti-SARS-CoV-2 immunoglobulin.
引用
下载
收藏
页码:611 / 618
页数:8
相关论文
共 50 条
  • [31] Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
    Shay Reicher
    Ronit Ratzon
    Shay Ben-Sahar
    Sharon Hermoni-Alon
    David Mossinson
    Yotam Shenhar
    Michael Friger
    Yaniv Lustig
    Sharon Alroy-Preis
    Emilia Anis
    Siegal Sadetzki
    Ehud Kaliner
    European Journal of Epidemiology, 2021, 36 : 727 - 734
  • [32] Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
    Arteaga-Mueller, Giovanna Yazmin
    Olivo-Gutierrez, Mara
    Favela-Aragon, Karla Lizbeth
    Hernandez-Castillo, Paola Alejandra
    Esquivel-Gomez, Victor
    Camacho-Ortiz, Adrian
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (02) : 457 - 458
  • [33] Broadly neutralizing antibodies against SARS-CoV-2 variants
    Linqi Zhang
    National Science Open, 2022, 1 (01) : 24 - 31
  • [34] Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
    Giovanna Yazmin Arteaga-Müller
    Mara Olivo-Gutierrez
    Karla Lizbeth Favela-Aragon
    Paola Alejandra Hernández-Castillo
    Victor Esquivel-Gomez
    Adrian Camacho-Ortiz
    International Urology and Nephrology, 2022, 54 : 457 - 458
  • [35] Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel
    Reicher, Shay
    Ratzon, Ronit
    Ben-Sahar, Shay
    Hermoni-Alon, Sharon
    Mossinson, David
    Shenhar, Yotam
    Friger, Michael
    Lustig, Yaniv
    Alroy-Preis, Sharon
    Anis, Emilia
    Sadetzki, Siegal
    Kaliner, Ehud
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2021, 36 (07) : 727 - 734
  • [36] Therapeutic antibodies and alternative formats against SARS-CoV-2
    Winiger, Rahel R.
    Perez, Laurent
    ANTIVIRAL RESEARCH, 2024, 223
  • [37] The humoral response and antibodies against SARS-CoV-2 infection
    Qi, Hai
    Liu, Bo
    Wang, Xinquan
    Zhang, Linqi
    NATURE IMMUNOLOGY, 2022, 23 (07) : 1008 - 1020
  • [38] Antibody cocktail effective against variants of SARS-CoV-2
    Liang, Kang-Hao
    Chiang, Pao-Yin
    Ko, Shih-Han
    Chou, Yu-Chi
    Lu, Ruei-Min
    Lin, Hsiu-Ting
    Chen, Wan-Yu
    Lin, Yi-Ling
    Tao, Mi-Hua
    Jan, Jia-Tsrong
    Wu, Han-Chung
    JOURNAL OF BIOMEDICAL SCIENCE, 2021, 28 (01)
  • [39] Antibody titers and protection against a SARS-CoV-2 infection
    Dimeglio, Chloe
    Herin, Fabrice
    Martin-Blondel, Guillaume
    Miedouge, Marcel
    Izopet, Jacques
    JOURNAL OF INFECTION, 2022, 84 (02) : 257 - 259
  • [40] Antibody cocktail effective against variants of SARS-CoV-2
    Kang-Hao Liang
    Pao-Yin Chiang
    Shih-Han Ko
    Yu-Chi Chou
    Ruei-Min Lu
    Hsiu-Ting Lin
    Wan-Yu Chen
    Yi-Ling Lin
    Mi-Hua Tao
    Jia-Tsrong Jan
    Han-Chung Wu
    Journal of Biomedical Science, 28